Validation of Nexfin Cardiac Output in Elderly Patients With Hip Fracture

December 3, 2014 updated by: University of Nottingham

Validation of the Nexfin Non-invasive Cardiac Output Monitor in Patients Undergoing Hip Fracture Repair

Measurement of how much blood the heart pumps may be useful in guiding how much intravenous fluid to give patients during surgery. The current monitors either require special drips (arterial and/or central lines) or a probe inserted into the oesophagus (food pipe) which may limit their use. Newer monitors are available which are completely non-invasive and seem to work well in younger patients. Patients with hip fracture are elderly and frail. The investigators wish to see whether the newer non-invasive monitor works well enough compared to the current monitors in this group of patients. If it does this may allow more of these patients to be monitored in this way.

Study Overview

Status

Terminated

Detailed Description

The investigators wish to compare the accuracy of the newer, non-invasive monitor (Nexfin) against a more established minimally invasive monitor (LiDCO). The LiDCO has a calibration system which allows the absolute accuracy of the Nexfin to be established.

Study Type

Observational

Enrollment (Actual)

6

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Notts
      • Nottingham, Notts, United Kingdom, NG7 2UH
        • Nottingham University Hospitals
    • Sussex
      • Brighton, Sussex, United Kingdom, BN2 5BE
        • Brighton and Sussex University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

80 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly patients undergoing surgical repair of hip fracture

Description

Inclusion Criteria:

  • Aged over 80
  • Able to give their own informed consent

Exclusion Criteria:

  • Severe valvular heart disease
  • Taking lithium

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bias and limits of agreement of Nexfin recorded cardiac output compared with LiDCOplus
Time Frame: During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia
Analysis of agreement between Nexfin cardiac output and the calibrated cardiac output measured by LiDCOplus
During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bias and limits of agreement for change in cardiac output measured by Nexfin compared with LiDCO
Time Frame: During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia
Comparison of relative changes in cardiac output recorded by Nexfin and LiDCO in response to intra-anaesthesia / intra-operative events (fluid administration, drug administration)
During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia
Utility of Nexfin monitor
Time Frame: Intra-operative - average duration about 1 hour
Proportion of time during anaesthesia and surgery when a valid signal is obtained from the Nexfin device.
Intra-operative - average duration about 1 hour
Adverse events associated with Nexfin monitor
Time Frame: Intra-operative - average duration about one hour
Recording of adverse events associated with use of the Nexfin monitor
Intra-operative - average duration about one hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Iain K Moppett, DM FRCA MRCP, University of Nottingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (ACTUAL)

October 1, 2013

Study Completion (ACTUAL)

October 1, 2013

Study Registration Dates

First Submitted

October 14, 2011

First Submitted That Met QC Criteria

November 15, 2011

First Posted (ESTIMATE)

November 18, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

December 4, 2014

Last Update Submitted That Met QC Criteria

December 3, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 11090 (DAIDS ES Registry Number)
  • 11/SW/0288 (OTHER: NRES)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Subscribe